These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 14351971)

  • 1. SUPPURATIVE lymphadenitis following intradermal BCG vaccination of preschool children.
    WHO Tuberculosis Research Office
    Bull World Health Organ; 1955; 12(1-2):143-67. PubMed ID: 14351971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
    Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
    Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Adverse events following immunization with BCG vaccine in Poland 1994-2000].
    Szczuka I
    Przegl Epidemiol; 2002; 56(2):205-16. PubMed ID: 12371352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BCG vaccination of neonates, infants, schoolchildren and adolescents. Part II: Safety of a vaccine with strain 1331 Copenhagen.
    Lehmann HG; Engelhardt H; Freudenstein H; Hennessen W; Quast U; Widmark RM
    Dev Biol Stand; 1979; 43():133-6. PubMed ID: 520665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuberculin sensitivity and skin lesions in children after vaccination with two batches of BCG vaccine.
    Vallishayee RS; Anantharaman DS; Gupte MD
    Indian J Lepr; 1998; 70(3):277-86. PubMed ID: 9801900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitization potential and reactogenicity of varying doses of BCG plus killed Mycobacterium leprae: an extended study.
    Gupte MD; Vallishayee RS; De Britto LJ; Anantharaman DS
    Int J Lepr Other Mycobact Dis; 1993 Dec; 61(4):563-70. PubMed ID: 8151187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Adverse events following BCG vaccination].
    Sagić L
    Med Pregl; 2004; 57 Suppl 1():41-7. PubMed ID: 15686221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bacillus Calmette-Guerin (BCG) lymphadenitis-changing trends and management.
    Nazir Z; Qazi SH
    J Ayub Med Coll Abbottabad; 2005; 17(4):16-8. PubMed ID: 16599027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Adverse events following BCG vaccination in infants and children up to 36 months of age].
    Gołebiowska M; Andrzejewska E; Stryjewska I; Baranowska H; Drazkiewicz A
    Przegl Epidemiol; 2008; 62(1):71-5. PubMed ID: 18536227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Surgical management of BCG vaccine-induced regional axillary lymphadenitis in HIV-infected children.
    Juzi JT; Sidler D; Moore SW
    S Afr J Surg; 2008 May; 46(2):52-5. PubMed ID: 18686936
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Investigations carried out to ascertain the dose-effect relationship of a BCG vaccine, strain 1331 Copenhagen, in neonates and young infants (author's transl)].
    Lehmann HG; Hennessen W; Engelhardt H; Freudenstein H; Widmark R; Weber-Oldecop H; Oehme J; Siegle-Joos H; Sinios A; Schmidt-Dohna W; Nevermann L; Beutnagel H; Schumann K; Schulz R; Kühl H; Schmöger R
    Zentralbl Bakteriol Orig B; 1978 Mar; 166(2-3):250-63. PubMed ID: 654682
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EXPERIMENTAL studies of vaccination, allergy, and immunity in tuberculosis. II. Effect of varying the dose of BCG.
    Tuberculosis Program, Public Health Service
    Bull World Health Organ; 1955; 12(1-2):31-45. PubMed ID: 14351967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety of intradermal Bacillus Calmette-Guerin vaccine for neonates in Eastern Saudi Arabia.
    Al-Salem AH; Kothari MR; AlHani HM; Oquaish MM; Khogeer SS; Desouky MS
    Saudi Med J; 2012 Feb; 33(2):172-6. PubMed ID: 22327758
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [BCG vaccination: characteristics of drugs and causes of vaccinal complications].
    Levi DT; Aksenova VA; Zakirova NR; Aleksandrova NV
    Probl Tuberk; 1999; (4):4-7. PubMed ID: 10479921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Lymphadenitis as a complication following vaccination with Bacillus Calmette-Guérin (BCG)].
    Cerdá de Palou E; de Santy HP
    Ned Tijdschr Geneeskd; 2003 Mar; 147(12):569-72. PubMed ID: 12693089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Koch's phenomenon after BCG vaccination and the two-step tuberculin test in elementary school children].
    Igari H; Onozaki I; Sunami Y; Suzuki K; Shimura A; Nagao K
    Kekkaku; 1998 Jun; 73(6):395-401. PubMed ID: 9695482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination technique, PPD reaction and BCG scarring in a cohort of children born in Guinea-Bissau 2000-2002.
    Roth A; Sodemann M; Jensen H; Poulsen A; Gustafson P; Gomes J; Djana Q; Jakobsen M; Garly ML; Rodrigues A; Aaby P
    Vaccine; 2005 Jun; 23(30):3991-8. PubMed ID: 15899539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A retrospective study on tuberculin in children under 19].
    Herranz Alvarez M; Vázquez Gallardo R; Minguella García I; Chouciño Garrido N; Otero Baamonde MI; Quiles Sotillo P
    An Esp Pediatr; 1996 Mar; 44(3):234-8. PubMed ID: 8830597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BCG scars in northern Malawi: sensitivity and repeatability of scar reading, and factors affecting scar size.
    Floyd S; Ponnighaus JM; Bliss L; Warndorff DK; Kasunga A; Mogha P; Fine PE
    Int J Tuberc Lung Dis; 2000 Dec; 4(12):1133-42. PubMed ID: 11144455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.